Clover, Decision time today or next week. $CLVWhich way is the price going to go?
From looking at the RSI, MACD and DMI, we are more likely to break to the upside.
Worth adding to the watchlist.
CLV trade ideas
$CLV - CLOVER CORP - Back testing resistanceClover has been having a good run. Back testing resistance. On the lower level timeframes Im getting some volume alerts so might be one to watch.
Clover Corporation Limited (CLV) is involved in the refining and sale of omega-3 oils and encapsulated bioactive ingredients for infant formula, children's foods, supplements and medical foods. CLV operates its businesses from five sites: a headquarter in Sydney; a manufacturing plant for tuna oils and related products in Altona; a product development R&D facility, technical support and marketing in Brisbane; the finance and IT departments in Gladstone Park; and a logistic and customer service office in the UK.
ASX:CLV - IS CLOVER CORP HEADING TO $2.70 A SHARE?Since July 2018, CLV looks to have been in the process of re-accumulation. The chart looks great.
We had the initial push down from $1.80 to the $1.30 area and notice the volume that came in and the close. This may have looked very weak at the time but there was a lot of stopping action taking place at this level. The strong hands were stepping in to stop the price. We saw a nice automatic rally back to the $1.70 level, before testing the $1.30 level again and notice the lower volume. Less supply down in this area again. Over the next 3-4 months the stock went into phase B, where the cause was being built in this stock - the bigger the cause, the bigger the effect. It was interesting to note that the highs were getting lower and this may have looked weak again. When we see this the stock will normally break the lows and spring back up. We saw that in late November. A final push to shake out the weak hands. The spring and the re-test were both on extremely low volume compared to the selling climax. The stock was ready to move higher. The stock rallied from $1.30 to $1.90, making a new high and a beautiful change in character and sign of strength. Phase D was complete with the back up to the creek, and look at the hidden buying that came in again, a nice spike in volume.
The stock now looks ready to mark-up. The point and figure chart currently projects an upward target of $2.70
Time will tell if the chart analysis is correct. I am not currently holding the stock but may look to enter on a pullback.
$CLV - CLOVER CORP - Feels like its setting up for a run.After a long sideways run it feels like it is starting to set up for another push.
Might be worth a watch.
Clover Corporation Limited is an Australia-based company, which is engaged in the refining and sale of natural oil. The Company is also engaged in the production of encapsulated powders, and the research and product development of functional food and infant nutrition ingredients. It focuses on developing nutrients for use in foods or as nutritional supplements. The Company provides lipid-based ingredients for the food industry. It focuses on the delivery of bioactive ingredients using encapsulation technology to produce ready-to-blend products containing tuna oil and other nutritional lipids. The Company offers an encapsulated oil and a food grade high docosahexaenoic acid (DHA) oil. It has a technology license for the encapsulation of marine and algal oils. The Company has a manufacturing plant for tuna oils and related products in Altona, Victoria. Its geographical segments include Australia/New Zealand, Asia, Europe and America.
CLV - Clover Corporation Limited slow and steady movementsShares price target around 19 per cent or $1.69
Company info.
Clover Corporation Limited is involved in the refining and sale of omega-3 oils and encapsulated bioactive ingredients for infant formula, children's foods, supplements and medical foods. CLV operates its businesses from five sites: a headquarter in Sydney; a manufacturing plant for tuna oils and related products in Altona; a product development R&D facility, technical support and marketing in Brisbane; the finance and IT departments in Gladstone Park; and a logistic and customer service office in the UK.
Products/services - DHA Oils:
The Company focusses on the delivery of bioactive ingredients using proprietary encapsulation technology to produce ready-to-blend products containing tuna oil and/or other nutritional lipids. Their triglyceride oil contains approximately 27% DHA and 35% total omega-3 fatty acids.
Products/services - DHA Powders:
The Company's Nu-MegaDriphorm powders utilise CSIRO's MicroMax technology under exclusive licence to microencapsulate nutritional oils. The patented technology allows up to a 50% oil payload with superior odour and taste masking. Nu-Mega Driphorm powders are used in a wide range of infant formula, follow-on formula, growing up milks and food applications.
Products/services - Microencapsulation technology:
The Company utilises a number of microencapsulation technologies that enable nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formula, foods and beverages. Developed through research and development, their proprietary technologies protect sensitive oils from oxidation allowing them to be incorporated into a range of end applications. ASX:CLV
Homepage
ASX:CLV - Tightening within flag but testing the lower side $CLVThis one can still go either way, just depends which side of the flag it breaks through.
However, adding the Bollinger Bands shows there's more frequent testing of the lower limits. It will be interesting to see how long this can act as support.
CLV.AX awaits for bearish confirmation2018.06.19 TA Report
Aussie Market Buy/Sell ratio = 0.40
Buys: 260 (12.6%)
Sells: 653 (31.7%)
Hold: 1148 (55.7%)
Let's see previous 5 days relative timing values by VectorVest on this stock:
19-Jun = 1.90
18-Jun = 1.84
15-Jun = 1.86
14-Jun = 1.88
13-Jun = 1.87
CLV.AX has a current Value of $1.41 per share, which is overvalued compared to its Price of $1.69 per share. Value is computed from forecasted earnings per share, forecasted earnings growth, profitability, interest, and inflation rates.
RT analyzes a stock's price trend. CLV.AX has a Relative Timing of 1.90, which is excellent on a scale of 0.00 to 2.00. RT is computed from an analysis of the direction, magnitude, and dynamics of a stock's price movements day-over-day, week-over-week, quarter-over-quarter and year-over-year. If a trend dissipates, RT will gravitate toward 1.00.
As RT hits close to 2.00, we considered CLV.AX is overbought atm. For a longer run, Midas Touch graph still look very well.
Let’s have a look on the technical analysis for more information:
Bearish Evening Star Alert
The Bearish Evening Star starts with a white candlestick and it should continue with a short candlestick (white or black) that opens with a gap up. We are waiting to see if there is a black candlestick appearing today should open at or lower than the highest level of the body of the second candlestick, and it should close well into the white candlestick that appears at the beginning of the pattern.
Today’s insights
We are waiting for confirmation for the above alert, possible retracement at Fib Ret 23.6% ($1.445). On the other hand, Ichimoku analysis found support at $1.455 (Kijun-sen)
